Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Apr;25(4):483–487. doi: 10.1128/aac.25.4.483

Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans.

N S Ryder, G Seidl, P F Troke
PMCID: PMC185557  PMID: 6375557

Abstract

Naftifine, a new antimycotic drug of the allylamine class, is a potent inhibitor of ergosterol biosynthesis in Candida albicans. Treated cells showed a dose-dependent drop in ergosterol content; the level was reduced by 60% at concentrations of greater than 50 mg/liter, causing total inhibition of growth. This inhibition coincided with a heavy accumulation of the sterol precursor squalene. Radiolabeling experiments showed that the inhibition of sterol synthesis was complete within 10 min of exposure of cells to the compound. Control cells incorporated [14C]acetate into nonsaponifiable lipids composed primarily of ergosterol, whereas naftifine-treated cells accumulated only labeled squalene. When the drug was removed by washing cells thoroughly in 1% Tween 80, the accumulated squalene was further metabolized to ergosterol. A similar pattern of inhibition was observed in sterol biosynthesis from [14C]mevalonate in a cell-free system. At 50 mg/liter, naftifine gave greater than 99% inhibition of sterol biosynthesis both in whole cells and in cell extracts of C. albicans. The primary action of naftifine appears to be the blocking of fungal squalene epoxidation.

Full text

PDF
483

Images in this article

485Image
on p.485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fryberg M., Oehlschlager A. C., Unrau A. M. Biosynthesis of ergosterol in yeast. Evidence for multiple pathways. J Am Chem Soc. 1973 Aug 22;95(17):5747–5757. doi: 10.1021/ja00798a051. [DOI] [PubMed] [Google Scholar]
  2. Fryberg M., Oehlschlager A. C., Unrau A. M. Sterol biosynthesis in antibiotic sensitive and resistant Candida. Arch Biochem Biophys. 1976 Mar;173(1):171–177. doi: 10.1016/0003-9861(76)90247-2. [DOI] [PubMed] [Google Scholar]
  3. Georgopoulos A., Petranyi G., Mieth H., Drews J. In vitro activity of naftifine, a new antifungal agent. Antimicrob Agents Chemother. 1981 Mar;19(3):386–389. doi: 10.1128/aac.19.3.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  5. Marriott M. S. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals. J Gen Microbiol. 1980 Mar;117(1):253–255. doi: 10.1099/00221287-117-1-253. [DOI] [PubMed] [Google Scholar]
  6. McLean-Bowen C. A., Parks L. W. Corresponding changes in kynurenine hydroxylase activity, membrane fluidity, and sterol composition in Saccharomyces cerevisiae mitochondria. J Bacteriol. 1981 Mar;145(3):1325–1333. doi: 10.1128/jb.145.3.1325-1333.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Meingassner J. G., Sleytr U., Petranyi G. Morphological changes induced by Naftifine, a new antifungal agent, in Trichophyton mentagrophytes. J Invest Dermatol. 1981 Dec;77(6):444–451. doi: 10.1111/1523-1747.ep12495814. [DOI] [PubMed] [Google Scholar]
  8. Minagawa H., Kitaura K., Nakamizo N. Effects of pH on the activity of ketoconazole against Candida albicans. Antimicrob Agents Chemother. 1983 Jan;23(1):105–107. doi: 10.1128/aac.23.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Petranyi G., Georgopoulos A., Mieth H. In vivo antimycotic activity of naftifine. Antimicrob Agents Chemother. 1981 Mar;19(3):390–392. doi: 10.1128/aac.19.3.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pierce A. M., Pierce H. D., Jr, Unrau A. M., Oehlschlager A. C. Lipid composition and polyene antibiotic resistance of Candida albicans mutants. Can J Biochem. 1978 Feb;56(2):135–142. doi: 10.1139/o78-023. [DOI] [PubMed] [Google Scholar]
  11. Van den Bossche H., Willemsens G., Cools W., Cornelissen F., Lauwers W. F., van Cutsem J. M. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis. Antimicrob Agents Chemother. 1980 Jun;17(6):922–928. doi: 10.1128/aac.17.6.922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. van den Bossche H., Willemsens G., Cools W., Lauwers W. F., Le Jeune L. Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem Biol Interact. 1978 Apr;21(1):59–78. doi: 10.1016/0009-2797(78)90068-6. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES